NPI: 1376915611 · BROOKLYN, NY 11204 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 10/27/2015
| Authorized Official | LIPSCHITZ, DAVID (PRESIDENT) |
| NPI Enumeration Date | 10/27/2015 |
Other providers sharing the same authorized official: LIPSCHITZ, DAVID
| Provider | City | State | Total Paid |
|---|---|---|---|
| THE DORAL INVESTORS GROUP, LLC DBA HOUSE CALLS HOME CARE | BROOKLYN | NY | $497.09M |
| THE DORAL INVESTORS GROUP LLC | BROOKLYN | NY | $34.29M |
| ALPHA & OMEGA KIDS DEVELOPMENTAL SERVICES | BROOKLYN | NY | $11.94M |
| DORAL MEDICAL AND MULTI SPECIALTY FACILITY LLC | BROOKLYN | NY | $7.77M |
| Year | Claims | Total Paid |
|---|---|---|
| 2023 | 12,912 | $147K |
| 2024 | 10,896 | $105K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90937 | 20,175 | 300 | $192K | |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 1,210 | 172 | $30K |
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 235 | 24 | $26K |
| J0882 | Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis) | 45 | 13 | $2K |
| J1756 | Injection, iron sucrose, 1 mg | 219 | 51 | $2K |
| A4657 | Syringe, with or without needle, each | 1,924 | 270 | $371.67 |